Skip to main content
main-content

Type 2 diabetes

Gastrointestinal disorders

08-12-2019 | Metabolic surgery | Highlight | News

Bariatric surgery linked to late adverse events

People who undergo bariatric surgery have a lower long-term risk for mortality, but a higher risk for adverse events such as gastrointestinal and nutritional disorders, compared with those who do not undergo surgery, researchers report.

Read the linked commentary from John Wilding

05-24-2019 | Non-alcoholic fatty liver disease | News

Diabetes patients at high risk of serious NAFLD outcomes

People with non-alcoholic fatty liver disease or non-alcoholic steatohepatitis are at particularly high risk for progression to cirrhosis or hepatocellular carcinoma if they have diabetes, say researchers.

12-05-2018 | Non-alcoholic fatty liver disease | Article

A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?

Lonardo A, Lugari S, Ballestri S et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1266-0

06-22-2018 | Gastroparesis | Review | Article

Diabetic gastroparesis: Principles and current trends in management

Krishnasamy S, Abell TL. Diabetes Ther (2018); 9 (Suppl 1): 1. doi: 10.1007/s13300-018-0454-9

03-20-2018 | Diet | News

DiRECT: Effects on insulin and liver fat revealed

Researchers from the DiRECT trial have reported large positive effects on liver fat and insulin secretion among people who achieved type 2 diabetes remission in response to a very-low-calorie diet.

02-07-2018 | Risk factors | Highlight | News

‘Subtle’ metabolic derangement seen decades before diabetes diagnosis

Research shows that changes in markers of the metabolic syndrome and fatty liver disease are present more than 20 years before people receive a diagnosis of type 2 diabetes.

12-29-2017 | Nephropathy | Review | Article

Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus

Nat Rev Endocrinol 2017; 14: 99–114. doi: 10.1038/nrendo.2017.173

10-27-2017 | Risk factors | Review | Article

Diabetes and the pancreatobiliary diseases

Shafqet M, Sharzehi K. Curr Treat Options Gastro 2017; 15: 508–519. doi: 10.1007/s11938-017-0163-x

10-06-2017 | Gastrointestinal disorders | Article

Screening for celiac disease in poorly controlled type 2 diabetes mellitus: Worth it or not?

Kizilgul M et al. BMC Endocr Disord 2017; 17: 62. doi: 10.1186/s12902-017-0212-4

09-13-2017 | Diet | EASD 2017 | News

Hypocaloric low-fat and low-carbohydrate diets beneficial in type 2 diabetes

Results of a randomized trial suggest that patients with type 2 diabetes experience metabolic benefits from a hypocaloric diet regardless of whether it is low in fat or low in carbohydrate content.

08-03-2017 | Ipragliflozin | News

Ipragliflozin and pioglitazone ‘equally beneficial’ for type 2 diabetes with NAFLD

Results of a randomized trial suggest that the sodium-glucose cotransporter 2 inhibitor ipragliflozin has equivalent efficacy to pioglitazone for the treatment of patients with type 2 diabetes complicated by nonalcoholic fatty liver disease.

01-27-2017 | Gastroparesis | Book chapter | Article

Diabetic gastroparesis

Tansel A, Husain N. In: Managing Gastrointestinal Complications of Diabetes. Edited by Sellin J. Adis, Cham, 2017. doi: 10.1007/978-3-319-48662-8_3

01-21-2017 | Gastrointestinal disorders | Article

The burdens, concerns, and quality of life of patients with gastroparesis

Yu D et al. Dig Dis Sci 2017; 62: 879–893. doi: 10.1007/s10620-017-4456-7

Image Credits